Hanne Melgaard Nielsen

Summary

Affiliation: Aarhus University Hospital
Country: Denmark

Publications

  1. ncbi Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials
    Marianne Kyndi
    Department of Experimental Clinical Oncology, Arhus University Hospital, Nørrebrogade, 8000 Arhus C, Denmark
    Breast Cancer Res 10:R24. 2008
  2. ncbi A simple method to test if the internal mammary lymph nodes are covered by the wide tangent technique in radiotherapy for high-risk breast cancer
    H M Nielsen
    Department of Oncology, Aarhus University Hospital, 8000 Aarhus C, Denmark
    Clin Oncol (R Coll Radiol) 15:17-24. 2003
  3. ncbi [Survey of a Cochrane review concerning sequencing of adjuvant chemotherapy and postoperative radiotherapy in breast cancer]
    Hanne Melgaard Nielsen
    Arhus Universitetshospital, Arhus Sygehus, Onkologisk afdeling
    Ugeskr Laeger 169:3101-4. 2007
  4. ncbi [Loco-regional recurrence of breast cancer]
    Hanne Melgaard Nielsen
    Arhus Universitetshospital, Arhus Sygehus, Onkologisk afdeling
    Ugeskr Laeger 169:3093-6. 2007
  5. ncbi Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials
    Hanne M Nielsen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 79:147-55. 2006
  6. ncbi Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies
    Hanne M Nielsen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus C, Denmark
    J Clin Oncol 24:2268-75. 2006
  7. ncbi Audit of the radiotherapy in the DBCG 82 b&c trials--a validation study of the 1,538 patients randomised to postmastectomy radiotherapy
    Hanne Melgaard Nielsen
    Department of Experimental Clinical Oncology, Department of Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 76:285-92. 2005
  8. ncbi Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group
    Marianne Kyndi
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Arhus Sygehus, Noerrebrogade 44, Building 5, 2, DK 8000 Aarhus C, Denmark
    J Clin Oncol 26:1419-26. 2008
  9. ncbi Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c
    M Kyndi
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 47:591-9. 2008
  10. ncbi Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c
    M Kyndi
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark
    Acta Oncol 47:608-17. 2008

Detail Information

Publications10

  1. ncbi Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials
    Marianne Kyndi
    Department of Experimental Clinical Oncology, Arhus University Hospital, Nørrebrogade, 8000 Arhus C, Denmark
    Breast Cancer Res 10:R24. 2008
    ..The purpose of the present study was to examine the importance of CA IX to response to postmastectomy radiotherapy in the larger scaled DBCG82 b and c studies...
  2. ncbi A simple method to test if the internal mammary lymph nodes are covered by the wide tangent technique in radiotherapy for high-risk breast cancer
    H M Nielsen
    Department of Oncology, Aarhus University Hospital, 8000 Aarhus C, Denmark
    Clin Oncol (R Coll Radiol) 15:17-24. 2003
    ..The current study was designed to test the validity of this assumption, and if possible, to correct the wide tangents without using computed tomography (CT) scanning...
  3. ncbi [Survey of a Cochrane review concerning sequencing of adjuvant chemotherapy and postoperative radiotherapy in breast cancer]
    Hanne Melgaard Nielsen
    Arhus Universitetshospital, Arhus Sygehus, Onkologisk afdeling
    Ugeskr Laeger 169:3101-4. 2007
  4. ncbi [Loco-regional recurrence of breast cancer]
    Hanne Melgaard Nielsen
    Arhus Universitetshospital, Arhus Sygehus, Onkologisk afdeling
    Ugeskr Laeger 169:3093-6. 2007
    ..Adjuvant chemotherapy is not applied to patients with LRR who have had radical loco-regional salvage treatment. Further studies are needed to elucidate this issue...
  5. ncbi Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials
    Hanne M Nielsen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 79:147-55. 2006
    ..The aim of the present study was to identify risk factors for loco-regional recurrence (LRR), to evaluate the treatment of LRR and to examine the prognosis after LRR...
  6. ncbi Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies
    Hanne M Nielsen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus C, Denmark
    J Clin Oncol 24:2268-75. 2006
    ..The aim of this analysis was to examine the overall disease recurrence pattern among patients randomly assigned to receive treatment with or without RT...
  7. ncbi Audit of the radiotherapy in the DBCG 82 b&c trials--a validation study of the 1,538 patients randomised to postmastectomy radiotherapy
    Hanne Melgaard Nielsen
    Department of Experimental Clinical Oncology, Department of Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 76:285-92. 2005
    ..The aim of the present study was to describe the delivered RT for the 1538 patients who were randomised to RT, and to evaluate the compliance with the RT guidelines...
  8. ncbi Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group
    Marianne Kyndi
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Arhus Sygehus, Noerrebrogade 44, Building 5, 2, DK 8000 Aarhus C, Denmark
    J Clin Oncol 26:1419-26. 2008
    ....
  9. ncbi Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c
    M Kyndi
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 47:591-9. 2008
    ....
  10. ncbi Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c
    M Kyndi
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark
    Acta Oncol 47:608-17. 2008
    ..To examine p53 and BCL2 expression in high-risk breast cancer patients randomized to postmastectomy radiotherapy (PMRT)...